Loading clinical trials...
Loading clinical trials...
An Open-label, Non-Randomized, Multi-Center Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered Into the Corpus Cavernous in Patients With Erectile Dysfunction.
Conditions
Interventions
Liposuction
AD-SVF Cell Injection
Locations
1
United States
Ageless Regenerative Institute LLC
Aventura, Florida, United States
Start Date
March 1, 2014
Primary Completion Date
November 1, 2017
Completion Date
December 1, 2017
Last Updated
November 24, 2017
NCT07480161
NCT07460960
NCT07431008
NCT06167733
NCT06968494
NCT06605508
Lead Sponsor
Ageless Regenerative Institute
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions